Skip to navigation Skip to content

News

Share

Researchers Report Success Reducing MS-like Disease in Mice

May 22, 2015

Researchers from the University of Montreal report that a molecule called "MCAM" helps immune cells to enter and attack the brain and spinal cord in mice with an MS-like disease. They found that blocking this molecule reduced disease activity in relapsing and progressive models of the disease. More study is needed to determine whether this blocking agent, now under development for psoriasis, has potential benefits for people with MS.

Read more on Medical News Today.

Read more about research in progressive MS.

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system. Symptoms range from numbness and tingling to blindness and paralysis, and there is currently no cure for MS. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. An estimated 1 million people live with MS in the United States. Most people with MS are diagnosed between the ages of 20 and 50, and it affects women three times more than men.

Share

© 2020 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.